AIM Chart
- 52-Week Range: $0.67 - $2.38
- Market Capitalization: $48.05M
- Short Percentage: 0%
- Target Price: $5.83
- Shares Outstanding: 47.99M
- Next Earnings: Mar 30
Catalysts
CategoryCatalyst
Earnings
AIM released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- AIM ImmunoTech to file Investigational New Drug application for Ampligen to treat long COVIDProactive Investors | May 18th
- AIM ImmunoTech Reports First Quarter 2022 Financial Results and Provides Corporate UpdateGlobeNewsWire | May 16th
- AIM ImmunoTech says Ampligen data supports synergistic potential with checkpoint blockade therapiesProactive Investors | April 21st
- AIM ImmunoTech engages CRO Amarex Clinical Research to manage Phase 2 of Ampligen studyProactive Investors | April 12th
- AIM ImmunoTech reports ‘strong' balance sheet to fund operations and clinical development programs through 2023Proactive Investors | April 1st
- AIM ImmunoTech Announces Abstract Accepted for Presentation at 15th Annual IHPBA World CongressGlobeNewsWire | March 28th
Company Info
Website: https://www.aimimmuno.com
Address: 2117 SW Highway 484, Ocala, FL, United States, 34473
Sector: Healthcare
Industry: Biotechnology
Full time employees: 21
Address: 2117 SW Highway 484, Ocala, FL, United States, 34473
Sector: Healthcare
Industry: Biotechnology
Full time employees: 21
$AIM oversold! Buy the dip
$AIM volume is almost nonexistent
$AIM we going up from here
$AIM let it ride
$AIM whats the target for Friday close?
$AIM soon
$AIM whats the news????
$AIM low volume
expect flat or negative close
$AIM buy the dip…smfh
$AIM let’s buy NOW!!!